Sementis

Business Services · Australia · 1-10 Employees

View Company Info for Free

Overview

Headquarters

25 North Ter, Hackney, South Australia, ...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Sementis

Sementis is an Australian unlisted public biotechnology company that is using its proprietary Sementis Copenhagen Vector (SCV) platform technology to generate a portfolio of innovative vaccine candidates for the prevention of infectious diseases and treatment of allergies and cancers. SCV is a novel vector platform that uses a replication-incompetent vaccinia virus to stimulate both B-cell and T-cell immune responses. The genes for disease antigens are added to the SCV, which upon vaccination elicits a potent immune response to the disease state. Unlike other poxvirus vectored vaccines, SCV vectored vaccines can be manufactured in a CHO cell substrate thus enabling superior upscaling abilities in bioreactors and manufacturing using a protein free production process.Explore more
Sementis's Social MediaPopular SearchesSementis LtdSementisSIC Code 87,873NAICS Code 54,541Show more

Sementis Org Chart

AC
Australia flag for contact location.

Chief Executive Officer

PhoneEmail
JH
Australia flag for contact location.

Scientific Advisor

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JZ
Australia flag for contact location.

Research Associate

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Sementis your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Sementis

Compare insights from companies similar to Sementis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Sementis

<$5M
1-10
Private
-
2009
$5.8M
11-50
Private
$10M
2014
CB
Christopher BaldwinCEO & Managing Director
$5.8M
51-200
Private
-
-
RC
Rachel ChangManager, Strategic Development
<$5M
11-50
Private
-
2015
HL
Helen LoyAntibodies Specialist
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2015
N/A
11-50
Public
$140M
2001
DM
Deanne MillerChief Operating Officer
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Sementis is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Sementis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sementis.

Sementis Tech Stack

A closer look at the technologies used by Sementis

Sementis News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Sementis

What is Sementis's official website?
Sementis's official website is www.sementis.com.au
What is Sementis's Revenue?
Sementis's revenue is <$5 Million
What is Sementis's SIC code?
Sementis's SIC: 87,873
What is Sementis's NAICS code?
Sementis's NAICS: 54,541
How many employees does Sementis have?
Sementis has 1-10 employees
What industry does Sementis belong to?
Sementis is in the industry of: Business Services, Research & Development
What is Sementis competition?
Sementis top competitors include: Jomar Life Research, Active Biochemku, Focus Bioscience, National Biologics Facility
What technology does Sementis use?
Some of the popular technologies that Sementis uses are: PHP, Cloudflare Website Optimization, Cloudflare CDN, Microsoft 365
What does Sementis do?

Sementis is an Australian unlisted public biotechnology company that is using its proprietary Sementis Copenhagen Vector (SCV) platform technology to generate a portfolio of innovative vaccine candidates for the prevention of infectious diseases and treatment of allergies and cancers. SCV is a novel vector platform that uses a replication-incompete... nt vaccinia virus to stimulate both B-cell and T-cell immune responses. The genes for disease antigens are added to the SCV, which upon vaccination elicits a potent immune response to the disease state. Unlike other poxvirus vectored vaccines, SCV vectored vaccines can be manufactured in a CHO cell substrate thus enabling superior upscaling abilities in bioreactors and manufacturing using a protein free production process.Read More

What are Sementis social media links?
Sementis Linkedin page Sementis Twitter page
Is Sementis a public company?
Sementis is private company therefore does not currently have an official ticker symbol
See more information about Sementis

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.